Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 8, 2015, Pages 1770-1773

  Sage, Andrew P ^a   Nus, Meritxell ^a   Baker, Lauren L ^a   Finigan, Alison J ^a   Masters, Leanne M ^a   Mallat, Ziad ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSERM   (France)

Author keywords

atherosclerosis; interleukins; lymphocytes

Indexed keywords

CHOLESTEROL; COLLAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN M; INSULIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; BIOLOGICAL MARKER; IL10 PROTEIN, MOUSE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; BODY WEIGHT; BONE MARROW CELL; CELL POLARITY; CELLULAR DISTRIBUTION; CHIMERA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; IMMUNOMODULATION; LIPID DIET; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION; ANIMAL; AORTA; AORTA DISEASE; BLOOD; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; TIME;

ANIMALS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; B-LYMPHOCYTES, REGULATORY; BIOLOGICAL MARKERS; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, LDL; TIME FACTORS;

EID: 84938125179     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305568     Document Type: Article

References (26)

1. Ylä-Herttuala S, Bentzon JF, Daemen M, ESC Working Group of Atherosclerosis and Vascular Biology Stabilization of atherosclerotic plaques: an update. Eur Heart J 2013 34 3251 3258. doi: 10.1093/eurheartj/eht301
2. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R., Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010 30 1282 1292. doi: 10.1161/ATVBAHA.108.179739
3. Legein B, Temmerman L, Biessen EA, Lutgens E., Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci 2013 70 3847 3869. doi: 10.1007/s00018-013-1289-1
4. Ait-Oufella H, Sage AP, Mallat Z, Tedgui A., Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res 2014 114 1640 1660. doi: 10.1161/CIRCRESAHA.114.302761
5. Tedder TF., B10 cells: a functionally defined regulatory B cell subset. J Immunol 2015 194 1395 1401. doi: 10.4049/jimmunol.1401329
6. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM., B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002 3 944 950. doi: 10.1038/ni833
7. Mauri C, Gray D, Mushtaq N, Londei M., Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003 197 489 501
8. Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA, Harris KA, Jones SA, Klein N, Mauri C., Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat Med 2014 20 1334 1339. doi: 10.1038/nm.3680
9. Wu L, Parekh VV, Hsiao J, Kitamura D, Van Kaer L., Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-Associated insulin resistance. Proc Natl Acad Sci U S A 2014 111 E4638 E4647. doi: 10.1073/pnas.1324052111
10. Caligiuri G, Nicoletti A, Poirier B, Hansson GK., Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 109 745 753. doi: 10.1172/JCI7272
11. Major AS, Fazio S, Linton MF., B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002 22 1892 1898
12. Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vré E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z., B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010 207 1579 1587. doi: 10.1084/jem.20100155
13. Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Murphy D, Loinard C, Binder CJ, Mallat Z., BAFF receptor deficiency reduces the development of atherosclerosis in mice-brief report. Arterioscler Thromb Vasc Biol 2012 32 1573 1576. doi: 10.1161/ATVBAHA.111.244731
14. Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh BH., Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010 185 4410 4419. doi: 10.4049/jimmunol.1000033
15. Tsiantoulas D, Sage AP, Mallat Z, Binder CJ., Targeting B cells in atherosclerosis: closing the gap from bench to bedside. Arterioscler Thromb Vasc Biol 2015 35 296 302. doi: 10.1161/ATVBAHA.114.303569
16. Gjurich BN, Taghavie-Moghadam PL, Ley K, Galkina EV., L-selectin deficiency decreases aortic B1a and Breg subsets and promotes atherosclerosis. Thromb Haemost 2014 112 803 811. doi: 10.1160/TH13-10-0865
17. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA., Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002 90 1064 1071
18. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A., Protective role of interleukin-10 in atherosclerosis. Circ Res 1999 85 e17 e24
19. Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H., Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 108 1232 1237. doi: 10.1161/01.CIR.0000089083.61317.A1
20. Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z., Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2004 24 1474 1478. doi: 10.1161/01.ATV.0000134378.86443.cd
21. Doran AC, Lipinski MJ, Oldham SN, B-cell aortic homing and atheroprotection depend on Id3. Circ Res 2012 110 e1 12. doi: 10.1161/CIRCRESAHA.111.256438
22. Hilgendorf I, Theurl I, Gerhardt LM, Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation 2014 129 1677 1687. doi: 10.1161/CIRCULATIONAHA.113.006381
23. Kelly JA, Griffin ME, Fava RA, Wood SG, Bessette KA, Miller ER, Huber SA, Binder CJ, Witztum JL, Morganelli PM., Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10. Cardiovasc Res 2010 85 224 231. doi: 10.1093/cvr/cvp300
24. Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh BH., B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011 109 830 840. doi: 10.1161/CIRCRESAHA.111.248542
25. Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO., Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009 120 417 426. doi: 10.1161/CIRCULATIONAHA.109.868158
26. Shen P, Roch T, Lampropoulou V, IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014 507 366 370. doi: 10.1038/nature12979